LNC
28
3
AA
27
5
AMG
33
-11
HAL
40
11
NRG
32
5
ZTS
38
4
IVZ
42
13
VRSK
54
2
TROW
37
8
NVDA
52
5
XEL
48
11
SO
48
6
CAH
44
7
MAC
53
5
IRM
33
5
AIZ
61
5
MPC
28
3
AAPL
64
3
LEG
16
2
WHR
61
3
LNC
28
3
AA
27
5
AMG
33
-11
HAL
40
11
NRG
32
5
ZTS
38
4
IVZ
42
13
VRSK
54
2
TROW
37
8
NVDA
52
5
XEL
48
11
SO
48
6
CAH
44
7
MAC
53
5
IRM
33
5
AIZ
61
5
MPC
28
3
AAPL
64
3
LEG
16
2
WHR
61
3
Financhill
Back

Lantheus Holdings Vs. Perspective Therapeutics Industry Stock Comparison

Sell
38

LNTH
Lantheus Holdings

Last Price:
$89.33
Seasonality Move:
14.8%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
38
Lantheus Holdings (LNTH) is a Sell

Is Lantheus Holdings a Buy, Sell or Hold?

  • The current Lantheus Holdings [LNTH] share price is $89.29. The Score for LNTH is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • LNTH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LNTH Stock Price Chart

What is Lantheus Holdings's stock price today?

  • The Lantheus Holdings share price today is $89.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LNTH is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

LNTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 44.02 Sell
Chaikin Money Flow: -1065905 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (84.29 - 93.35) Buy
Bollinger Bands (100): (90.29 - 109.87) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.72 - 15.04) Sell

LNTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.85 Sell
20-day SMA: 90.71 Sell
50-day SMA: 96.46 Sell
200-day SMA: 89.01 Buy
8-day EMA: 91.22 Sell
20-day EMA: 91.13 Sell
50-day EMA: 94.3 Sell
200-day EMA: 90.59 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.99 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.01 Sell

Lantheus Holdings Earnings Growth & LNTH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $0.11 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Lantheus Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):